Chemical biology approaches to designing defined carbohydrate vaccines

Chemistry and Biology

Volumn 21, Issue 1, 2014, Pages 38-50

  Anish, Chakkumkal ^a   Schumann, Benjamin ^a,b   Pereira, Claney Lebev ^a   Seeberger, Peter H ^a,b  

^a MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CARBOHYDRATE ANTIGEN; CARBOHYDRATE VACCINE; EPITOPE; OLIGOSACCHARIDE; UNCLASSIFIED DRUG; VACCINE; ANTIGEN; POLYSACCHARIDE;

ANTIBODY SCREENING; ANTIGEN ANTIBODY REACTION; B LYMPHOCYTE; CHEMICAL ANALYSIS; DRUG DESIGN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; CHEMISTRY; HUMAN; IMMUNOLOGY; SYNTHESIS;

ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; DRUG DESIGN; HUMANS; POLYSACCHARIDES; VACCINES;

EID: 84892633304     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2014.01.002     Document Type: Review

References (156)

1. A.K. Abbas, A.H. Lichtman, and S. Pillai Cellular and Molecular Immunology 2012 Elsevier Saunders Philadelphia
2. A. Acosta-Serrano, I.C. Almeida, L.H. Freitas-Junior, N. Yoshida, and S. Schenkman The mucin-like glycoprotein super-family of Trypanosoma cruzi: structure and biological roles Mol. Biochem. Parasitol. 114 2001 143 150 (Pubitemid 32510751)
3. G. Ada, and D. Isaacs Carbohydrate-protein conjugate vaccines Clin. Microbiol. Infec. 9 2003 79 85 (Pubitemid 36527051)
4. R. Adamo, M.R. Romano, F. Berti, R. Leuzzi, M. Tontini, E. Danieli, E. Cappelletti, O.S. Cakici, E. Swennen, and V. Pinto et al. Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide ACS Chem. Biol. 7 2012 1420 1428
5. C. Anish, X. Guo, A. Wahlbrink, and P.H. Seeberger Plague detection by anti-carbohydrate antibodies Angew. Chem. Int. Ed. Engl. 52 2013 9524 9528
6. C. Anish, C.E. Martin, A. Wahlbrink, C. Bogdan, P. Ntais, M. Antoniou, and P.H. Seeberger Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of Leishmania ACS Chem. Biol. 8 2013 2412 2422
7. S.R. Arepalli, C.P. Glaudemans, G.D. Daves Jr.; P. Kovac, and A. Bax Identification of protein-mediated indirect NOE effects in a disaccharide-Fab' complex by transferred ROESY J. Magn. Reson. B. 106 1995 195 198
8. R. Arnon, and M.H.V. Van Regenmortel Structural basis of antigenic specificity and design of new vaccines FASEB J. 6 1992 3265 3274
9. R.A. Ashmus, N.S. Schocker, Y. Cordero-Mendoza, A.F. Marques, E.Y. Monroy, A. Pardo, L. Izquierdo, M. Gállego, J. Gascon, I.C. Almeida, and K. Michael Potential use of synthetic α-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease Org. Biomol. Chem. 11 2013 5579 5583
10. N. Azzouz, F. Kamena, and P.H. Seeberger Synthetic glycosylphosphatidylinositol as tools for glycoparasitology research OMICS 14 2010 445 454
11. B. Benaissa-Trouw, D.J. Lefeber, J.P. Kamerling, J.F. Vliegenthart, K. Kraaijeveld, and H. Snippe Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice Infect. Immun. 69 2001 4698 4701 (Pubitemid 32574477)
12. A. Berkin, B. Coxon, and V. Pozsgay Towards a synthetic glycoconjugate vaccine against Neisseria meningitidis A Chemistry 8 2002 4424 4433 (Pubitemid 35177766)
13. E.G. Bremer, S.B. Levery, S. Sonnino, R. Ghidoni, S. Canevari, R. Kannagi, and S.I. Hakomori Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland J. Biol. Chem. 259 1984 14773 14777 (Pubitemid 15222206)
14. J.R. Brisson, H. Baumann, A. Imberty, S. Pérez, and H.J. Jennings Helical epitope of the group B meningococcal alpha(2-8)-linked sialic acid polysaccharide Biochemistry 31 1992 4996 5004
15. D.R. Bundle, C. Nycholat, C. Costello, R. Rennie, and T. Lipinski Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody ACS Chem. Biol. 7 2012 1754 1763
16. D.A. Calarese, C.N. Scanlan, M.B. Zwick, S. Deechongkit, Y. Mimura, R. Kunert, P. Zhu, M.R. Wormald, R.L. Stanfield, and K.H. Roux et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition Science 300 2003 2065 2071 (Pubitemid 36760127)
17. O. Calin, S. Eller, and P.H. Seeberger Automated polysaccharide synthesis: assembly of a 30mer mannoside Angew. Chem. Int. Ed. Engl. 52 2013 5862 5865
18. N.I.A. Carlin, T. Wehler, and A.A. Lindberg Shigella flexneri O-antigen epitopes: chemical and immunochemical analyses reveal that epitopes of type III and group 6 antigens are identical Infect. Immun. 53 1986 110 115 (Pubitemid 16084372)
19. P. Chong, N. Chan, A. Kandil, B. Tripet, O. James, Y.P. Yang, S.P. Shi, and M. Klein A strategy for rational design of fully synthetic glycopeptide conjugate vaccines Infect. Immun. 65 1997 4918 4925 (Pubitemid 27513530)
20. K.-C. Chu, C.-T. Ren, C.-P. Lu, C.-H. Hsu, T.-H. Sun, J.-L. Han, B. Pal, T.-A. Chao, Y.-F. Lin, and S.-H. Wu et al. Efficient and stereoselective synthesis of α(2→9) oligosialic acids: from monomers to dodecamers Angew. Chem. Int. Ed. Engl. 50 2011 9391 9395
21. M.V. Chuenkova, and M. Pereiraperrin Neurodegeneration and neuroregeneration in Chagas disease Adv. Parasitol. 76 2011 195 233
22. D. Cimini, O.F. Restaino, A. Catapano, M. De Rosa, and C. Schiraldi Production of capsular polysaccharide from Escherichia coli K4 for biotechnological applications Appl. Microbiol. Biotechnol. 85 2010 1779 1787
23. M.-J. Clément, A. Fortuné, A. Phalipon, V. Marcel-Peyre, C. Simenel, A. Imberty, M. Delepierre, and L.A. Mulard Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a J. Biol. Chem. 281 2006 2317 2332 (Pubitemid 43845823)
24. P. Costantino, R. Rappuoli, and F. Berti The design of semi-synthetic and synthetic glycoconjugate vaccines Expert. Opin. Drug. Discov. 6 2011 1045 1066
25. G. Csako, E.A. Suba, C.M. Tsai, L.F. Mocca, and R.J. Elin Dose-dependent changes in the antigenicity of bacterial endotoxin exposed to ionizing radiation J. Clin. Lab. Immunol. 24 1987 193 198 (Pubitemid 18069975)
26. J.L. de Paz, and P.H. Seeberger Recent advances and future challenges in glycan microarray technology Methods Mol. Biol. 808 2012 1 12
27. P.R. Dormitzer, G. Grandi, and R. Rappuoli Structural vaccinology starts to deliver Nat. Rev. Microbiol. 10 2012 807 813
28. M. El Sabbagh, C. Galanos, L. Bertók, G. Füst, and O. Lüderitz Effect of ionizing radiation on chemical and biological properties of Salmonella minnesota R595 lipopolysaccharide Acta Microbiol. Acad. Sci. Hung. 29 1982 255 261
29. P.M. Enríquez-Navas, M. Marradi, D. Padro, J. Angulo, and S. Penadés A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands Chemistry 17 2011 1547 1560
30. S. Esposito, S. Tansey, A. Thompson, A. Razmpour, J. Liang, T.R. Jones, G. Ferrera, A. Maida, G. Bona, and C. Sabatini et al. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers Clin. Vaccine Immunol. 17 2010 1017 1026
31. European Medicines Agency Assessment Report for Synflorix 2009 European Medicines Agency London
32. S.V. Evans, B.W. Sigurskjold, H.J. Jennings, J.R. Brisson, R. To, W.C. Tse, E. Altman, M. Frosch, C. Weisgerber, and H.D. Kratzin et al. Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for alpha-(2 - >8)-polysialic acid Biochemistry 34 1995 6737 6744
33. T. Feizi, F. Fazio, W.C. Chai, and C.H. Wong Carbohydrate microarrays - a new set of technologies at the frontiers of glycomics Curr. Opin. Struct. Biol. 13 2003 637 645 (Pubitemid 37244119)
34. J. Finne, and P.H. Mäkelä Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. Involvement of a long oligosaccharide segment in molecular interactions of polysialic acid J. Biol. Chem. 260 1985 1265 1270 (Pubitemid 15173647)
35. P.C. Fusco, E.K. Farley, C.H. Huang, S. Moore, and F. Michon Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation Clin. Vaccine Immunol. 14 2007 577 584
36. J. Ganeshapillai, E. Vinogradov, J. Rousseau, J.S. Weese, and M.A. Monteiro Clostridium difficile cell-surface polysaccharides composed of pentaglycosyl and hexaglycosyl phosphate repeating units Carbohydr. Res. 343 2008 703 710
37. Q. Gao, M. Tontini, G. Brogioni, A. Nilo, S. Filippini, C. Harfouche, L. Polito, M.R. Romano, P. Costantino, and F. Berti et al. Immunoactivity of protein conjugates of carba analogues from Neisseria meningitidis a capsular polysaccharide ACS Chem. Biol. 8 2013 2561 2567
38. P.J. Garegg, and L. Maron Improved Synthesis of 3,4,6-Tri-O-Benzyl-Alpha- D-Mannopyranosides Acta Chem. Scand. B 33 1979 39 41
39. P.J. Garegg, and T. Norberg Syntheses of the Biological Repeating Units of Salmonella Serogroup-a, Serogroup-B and Serogroup-D1 O-Antigenic Polysaccharides J. Chem. Soc. Perk. T 1 1982 2973 2982
40. P.J. Garegg, S. Oscarson, and U. Tedebark Synthesis of the repeating unit of the capsular polysaccharide of Streptococcus pneumoniae type 3 as a building block suitable for formation of oligomers J. Carbohydr. Chem. 17 1998 587 594
41. T. Gilewski, G. Ragupathi, S. Bhuta, L.J. Williams, C. Musselli, X.F. Zhang, K.P. Bencsath, K.S. Panageas, J. Chin, and C.A. Hudis et al. Immunization of metastatic breast cancer patients with a fully synthetic H conjugate: a phase I trial Proc. Natl. Acad. Sci. USA 98 2001 3270 3275 (Pubitemid 32220835)
42. D. Goldblatt, R.J. Levinsky, and M.W. Turner Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood J. Infect. Dis. 166 1992 632 634
43. V.M. Gonçalves, T.C. Zangirolami, R.L. Giordano, I. Raw, M.M. Tanizaki, and R.C. Giordano Optimization of medium and cultivation conditions for capsular polysaccharide production by Streptococcus pneumoniae serotype 23F Appl. Microbiol. Biotechnol. 59 2002 713 717
44. J. González-Outeiriño, R. Kadirvelraj, and R.J. Woods Structural elucidation of type III group B Streptococcus capsular polysaccharide using molecular dynamics simulations: the role of sialic acid Carbohydr. Res. 340 2005 1007 1018 (Pubitemid 40380830)
45. J. Guiard, E. Paszkiewicz, J. Sadowska, and D.R. Bundle Design and synthesis of a universal antigen to detect brucellosis Angew. Chem. Int. Ed. Engl. 52 2013 7181 7185
46. J. Hansson, P.J. Garegg, and S. Oscarson Syntheses of anomerically phosphodiester-linked oligomers of the repeating units of the Haemophilus influenzae types c and f capsular polysaccharides J. Org. Chem. 66 2001 6234 6243 (Pubitemid 32868354)
47. L. Herfurth, B. Ernst, B. Wagner, D. Ricklin, D.S. Strasser, J.L. Magnani, A.J. Benie, and T. Peters Comparative epitope mapping with saturation transfer difference NMR of sialyl Lewis(a) compounds and derivatives bound to a monoclonal antibody J. Med. Chem. 48 2005 6879 6886 (Pubitemid 41533109)
48. M.C. Hewitt, and P.H. Seeberger Automated solid-phase synthesis of a branched Leishmania cap tetrasaccharide Org. Lett. 3 2001 3699 3702 (Pubitemid 33625444)
49. M.C. Hewitt, D.A. Snyder, and P.H. Seeberger Rapid synthesis of a glycosylphosphatidylinositol-based malaria vaccine using automated solid-phase oligosaccharide synthesis J. Am. Chem. Soc. 124 2002 13434 13436 (Pubitemid 35285919)
50. H. Jang, Y.K. Yoon, J.A. Kim, H.S. Kim, S.J. An, J.H. Seo, C. Cui, and R. Carbis Optimization of Vi capsular polysaccharide production during growth of Salmonella enterica serotype Typhi Ty2 in a bioreactor J. Biotechnol. 135 2008 71 77
51. W.T.M. Jansen, S. Hogenboom, M.J.L. Thijssen, J.P. Kamerling, J.F.G. Vliegenthart, J. Verhoef, H. Snippe, and A.F.M. Verheul Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice Infect. Immun. 69 2001 787 793 (Pubitemid 32109540)
52. H. Jennings The role of sialic acid in the formation of protective conformational bacterial polysaccharide epitopes P. Kosma, S. Müller-Loennies, Anticarbohydrate Antibodies 2012 Springer Vienna 55 73
53. S.D. Jin, Y.M. Kim, H.K. Kang, S.J. Jung, and D. Kim Optimization of capsular polysaccharide production by Streptococcus pneumoniae type 3 J. Microbiol. Biotechnol. 19 2009 1374 1378
54. H.L. Johnson, M. Deloria-Knoll, O.S. Levine, S.K. Stoszek, L. Freimanis Hance, R. Reithinger, L.R. Muenz, and K.L. O'Brien Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project PLoS Med. 7 2010 e1000348
55. C. Jones The regulatory framework for glycoconjugate vaccines R. Roy, Carbohydrate-Based Vaccines 2008 American Chemical Society Washington 21 35
56. C. Jones, and F. Currie Control of components of bacterial polysaccharide vaccines by physical methods Biologicals 19 1991 41 47
57. C. Jones, F. Currie, and M.J. Forster N.m.r. and conformational analysis of the capsular polysaccharide from Streptococcus pneumoniae type 4 Carbohydr. Res. 221 1991 95 121
58. A. Kabanova, I. Margarit, F. Berti, M.R. Romano, G. Grandi, G. Bensi, E. Chiarot, D. Proietti, E. Swennen, and E. Cappelletti et al. Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate Vaccine 29 2010 104 114
59. R. Kadirvelraj, J. Gonzalez-Outeiriño, B.L. Foley, M.L. Beckham, H.J. Jennings, S. Foote, M.G. Ford, and R.J. Woods Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae Proc. Natl. Acad. Sci. USA 103 2006 8149 8154 (Pubitemid 43801067)
60. F. Kamena, M. Tamborrini, X.Y. Liu, Y.U. Kwon, F. Thompson, G. Pluschke, and P.H. Seeberger Synthetic GPI array to study antitoxic malaria response Nat. Chem. Biol. 4 2008 238 240 (Pubitemid 351414831)
61. K. Kato, Y. Yamaguchi, and Y. Arata Stable-isotope-assisted NMR approaches to glycoproteins using immunoglobulin G as a model system Prog. Nucl. Magn. Reson. Spectrosc. 56 2010 346 359
62. S. Khan, E. Rodriguez, R. Patel, J. Gor, B. Mulloy, and S.J. Perkins The solution structure of heparan sulfate differs from that of heparin: implications for function J. Biol. Chem. 286 2011 24842 24854
63. V. Kudryashov, P.W. Glunz, L.J. Williams, S. Hintermann, S.J. Danishefsky, and K.O. Lloyd Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice Proc. Natl. Acad. Sci. USA 98 2001 3264 3269 (Pubitemid 32220834)
64. Y.U. Kwon, R.L. Soucy, D.A. Snyder, and P.H. Seeberger Assembly of a series of malarial glycosylphosphatidylinositol anchor oligosaccharides Chemistry 11 2005 2493 2504 (Pubitemid 40538108)
65. H.-K. Lee, C.N. Scanlan, C.-Y. Huang, A.Y. Chang, D.A. Calarese, R.A. Dwek, P.M. Rudd, D.R. Burton, I.A. Wilson, and C.-H. Wong Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody Angew. Chem. Int. Ed. Engl. 43 2004 1000 1003 (Pubitemid 39258001)
66. J.C. Lee, W.A. Greenberg, and C.H. Wong Programmable reactivity-based one-pot oligosaccharide synthesis Nat. Protoc. 1 2006 3143 3152
67. L. Legnani, S. Ronchi, S. Fallarini, G. Lombardi, F. Campo, L. Panza, L. Lay, L. Poletti, L. Toma, F. Ronchetti, and F. Compostella Synthesis, molecular dynamics simulations, and biology of a carba-analogue of the trisaccharide repeating unit of Streptococcus pneumoniae 19F capsular polysaccharide Org. Biomol. Chem. 7 2009 4428 4436
68. X. Lemercinier, and C. Jones Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production Carbohydr. Res. 296 1996 83 96 (Pubitemid 27008331)
69. T. Lipinski, A. Fitieh, J. St Pierre, H.L. Ostergaard, D.R. Bundle, and N. Touret Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating beta-glucan J. Immunol. 190 2013 4116 4128
70. X. Liu, S. Siegrist, M. Amacker, R. Zurbriggen, G. Pluschke, and P.H. Seeberger Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate ACS Chem. Biol. 1 2006 161 164
71. Y. Liu, A.S. Palma, and T. Feizi Carbohydrate microarrays: key developments in glycobiology Biol. Chem. 390 2009 647 656
72. H. Maaheimo, P. Kosma, L. Brade, H. Brade, and T. Peters Mapping the binding of synthetic disaccharides representing epitopes of chlamydial lipopolysaccharide to antibodies with NMR Biochemistry 39 2000 12778 12788
73. C.R. MacKenzie, and H.J. Jennings Characterization of polysaccharide conformational epitopes by surface plasmon resonance Methods Enzymol. 363 2003 340 354 (Pubitemid 37267682)
74. O. Mäkelä, F. Péterfy, I.G. Outschoorn, A.W. Richter, and I. Seppälä Immunogenic properties of alpha (1 - - 6) dextran, its protein conjugates, and conjugates of its breakdown products in mice Scand. J. Immunol. 19 1984 541 550 (Pubitemid 14084460)
75. F. Marcelo, F.J. Cañada, and J. Jiménez-Barbero The interaction of saccharides with antibodies. a 3D view by using NMR P. Kosma, S. Müller-Loennies, Anticarbohydrate Antibodies 2012 Springer Vienna 385 402
76. C.E. Martin, M.W. Weishaupt, and P.H. Seeberger Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit Chem. Commun. (Camb.) 47 2011 10260 10262
77. C.E. Martin, F. Broecker, S. Eller, M.A. Oberli, C. Anish, C.L. Pereira, and P.H. Seeberger Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine Chem. Commun. (Camb.) 49 2013 7159 7161
78. C.E. Martin, F. Broecker, M.A. Oberli, J. Komor, J. Mattner, C. Anish, and P.H. Seeberger Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope J. Am. Chem. Soc. 135 2013 9713 9722
79. M. Mayer, and B. Meyer Characterization of ligand binding by saturation transfer difference NMR spectroscopy Angew. Chem. Int. Ed. 38 1999 1784 1788 (Pubitemid 29290947)
80. M. Mayer, and B. Meyer Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor J. Am. Chem. Soc. 123 2001 6108 6117 (Pubitemid 32888480)
81. S.K. Mazmanian, and D.L. Kasper The love-hate relationship between bacterial polysaccharides and the host immune system Nat. Rev. Immunol. 6 2006 849 858 (Pubitemid 44631653)
82. L.I. McCall, W.W. Zhang, and G. Matlashewski Determinants for the development of visceral leishmaniasis disease PLoS Pathog. 9 2013 e1003053
83. T.B. McNeely, J.M. Staub, C.M. Rusk, M.J. Blum, and J.J. Donnelly Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques Infect. Immun. 66 1998 3705 3710 (Pubitemid 28347827)
84. A.M. Mejia, B.S. Hall, M.C. Taylor, A. Gómez-Palacio, S.R. Wilkinson, O. Triana-Chávez, and J.M. Kelly Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population J. Infect. Dis. 206 2012 220 228
85. F. Michon, R. Chalifour, R. Feldman, M. Wessels, D.L. Kasper, A. Gamian, V. Pozsgay, and H.J. Jennings The alpha-L-(1 - - 2)-trirhamnopyranoside epitope on the group-specific polysaccharide of group B streptococci Infect. Immun. 59 1991 1690 1696
86. F. Michon, S.L. Moore, J. Kim, M.S. Blake, F.I. Auzanneau, B.D. Johnston, M.A. Johnson, and B.M. Pinto Doubly branched hexasaccharide epitope on the cell wall polysaccharide of group A streptococci recognized by human and rabbit antisera Infect. Immun. 73 2005 6383 6389 (Pubitemid 41368799)
87. M.J. Milton, and D.R. Bundle Observation of the anti conformation of a glycosidic linkage in an antibody-bound oligosaccharide J. Am. Chem. Soc. 120 1998 10547 10548 (Pubitemid 28500364)
88. J.J. Mond, A. Lees, and C.M. Snapper T cell-independent antigens type 2 Annu. Rev. Immunol. 13 1995 655 692
89. M.A. Monteiro, Z. Ma, L. Bertolo, Y. Jiao, L. Arroyo, D. Hodgins, M. Mallozzi, G. Vedantam, M. Sagermann, J. Sundsmo, and H. Chow Carbohydrate-based Clostridium difficile vaccines Expert Rev. Vaccines 12 2013 421 431
90. L. Morelli, L. Poletti, and L. Lay Carbohydrates and immunology: synthetic oligosaccharide antigens for vaccine formulation Eur. J. Org. Chem. 2011 2011 5723 5777
91. D.M. Musher, M.J. Luchi, D.A. Watson, R. Hamilton, and R.E. Baughn Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide J. Infect. Dis. 161 1990 728 735 (Pubitemid 20120232)
92. M. Nagae, A. Ikeda, M. Hane, S. Hanashima, K. Kitajima, C. Sato, and Y. Yamaguchi Crystal structure of anti-polysialic acid antibody single chain Fv fragment complexed with octasialic acid: insight into the binding preference for polysialic acid J. Biol. Chem. 288 2013 33784 33796
93. F. Ni, and Y. Zhu Accounting for ligand-protein interactions in the relaxation-matrix analysis of transferred nuclear Overhauser effects J. Magn. Reson. B. 103 1994 180 184
94. M.C. Nunes, W. Dones, C.A. Morillo, J.J. Encina, A.L. Ribeiro Council on Chagas Disease of the Interamerican Society of Cardiology Chagas disease: an overview of clinical and epidemiological aspects J. Am. Coll. Cardiol. 62 2013 767 776
95. C.M. Nycholat, W. Peng, R. McBride, A. Antonopoulos, R.P. de Vries, Z. Polonskaya, M.G. Finn, A. Dell, S.M. Haslam, and J.C. Paulson Synthesis of biologically active N- and O-linked glycans with multisialylated poly-N-acetyllactosamine extensions using P. damsela α2-6 sialyltransferase J. Am. Chem. Soc. 135 2013 18280 18283
96. M.A. Oberli, M. Tamborrini, Y.H. Tsai, D.B. Werz, T. Horlacher, A. Adibekian, D. Gauss, H.M. Möller, G. Pluschke, and P.H. Seeberger Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharide J. Am. Chem. Soc. 132 2010 10239 10241
97. M.A. Oberli, M.L. Hecht, P. Bindschädler, A. Adibekian, T. Adam, and P.H. Seeberger A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenic Chem. Biol. 18 2011 580 588
98. A.R. Parameswar, I.H. Park, R. Saksena, P. Kovác, M.H. Nahm, and A.V. Demchenko Synthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharides ChemBioChem 10 2009 2893 2899
99. S. Park, J.C. Gildersleeve, O. Blixt, and I. Shin Carbohydrate microarrays Chem. Soc. Rev. 42 2013 4310 4326
100. M.G. Paulick, and C.R. Bertozzi The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins Biochemistry 47 2008 6991 7000 (Pubitemid 351956348)
101. C.C. Peeters, D. Evenberg, P. Hoogerhout, H. Käyhty, L. Saarinen, C.A. van Boeckel, G.A. van der Marel, J.H. van Boom, and J.T. Poolman Synthetic trimer and tetramer of 3-beta-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys Infect. Immun. 60 1992 1826 1833
102. R. Pejchal, K.J. Doores, L.M. Walker, R. Khayat, P.S. Huang, S.K. Wang, R.L. Stanfield, J.P. Julien, A. Ramos, and M. Crispin et al. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield Science 334 2011 1097 1103
103. A. Phalipon, M. Tanguy, C. Grandjean, C. Guerreiro, F. Bélot, D. Cohen, P.J. Sansonetti, and L.A. Mulard A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection J. Immunol. 182 2009 2241 2247
104. O.J. Plante, E.R. Palmacci, and P.H. Seeberger Automated solid-phase synthesis of oligosaccharides Science 291 2001 1523 1527 (Pubitemid 32179214)
105. J. Poolman, and R. Borrow Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines Expert Rev. Vaccines 10 2011 307 322
106. V. Pozsgay, C.Y. Chu, L. Pannell, J. Wolfe, J.B. Robbins, and R. Schneerson Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1 Proc. Natl. Acad. Sci. USA 96 1999 5194 5197 (Pubitemid 29214559)
107. V. Pozsgay, J. Kubler-Kielb, B. Coxon, P. Santacroce, J.B. Robbins, and R. Schneerson Synthetic oligosaccharides as tools to demonstrate cross-reactivity between polysaccharide antigens J. Org. Chem. 77 2012 5922 5941
108. N.S. Pujar, N.F. Huang, C.L. Daniels, L. Dieter, M.G. Gayton, and A.L. Lee Base hydrolysis of phosphodiester bonds in pneumococcal polysaccharides Biopolymers 75 2004 71 84 (Pubitemid 39213960)
109. C. Rademacher, G.K. Shoemaker, H.S. Kim, R.B. Zheng, H. Taha, C. Liu, R.C. Nacario, D.C. Schriemer, J.S. Klassen, T. Peters, and T.L. Lowary Ligand specificity of CS-35, a monoclonal antibody that recognizes mycobacterial lipoarabinomannan: a model system for oligofuranoside-protein recognition J. Am. Chem. Soc. 129 2007 10489 10502 (Pubitemid 47330268)
110. R. Rappuoli, S. Black, and P.H. Lambert Vaccine discovery and translation of new vaccine technology Lancet 378 2011 360 368
111. F. Rebeaud, and M.F. Bachmann Immunization strategies for Clostridium difficile infections Expert Rev. Vaccines 11 2012 469 479
112. C.W. Reid, E. Vinogradov, J. Li, H.C. Jarrell, S.M. Logan, and J.R. Brisson Structural characterization of surface glycans from Clostridium difficile Carbohydr. Res. 354 2012 65 73
113. C.D. Rillahan, and J.C. Paulson Glycan microarrays for decoding the glycome Annu. Rev. Biochem. 80 2011 797 823
114. J.B. Robbins, J. Kubler-Kielb, E. Vinogradov, C. Mocca, V. Pozsgay, J. Shiloach, and R. Schneerson Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates Proc. Natl. Acad. Sci. USA 106 2009 7974 7978
115. D. Safari, H.A.T. Dekker, J.A.F. Joosten, D. Michalik, A.C. de Souza, R. Adamo, M. Lahmann, A. Sundgren, S. Oscarson, J.P. Kamerling, and H. Snippe Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14 Infect. Immun. 76 2008 4615 4623
116. D. Safari, G. Rijkers, and H. Snippe The future of synthetic carbohydrate vaccines: immunological studies on Streptococcus pneumoniae type 14 D.N. Karunaratne, The Complex World of Polysaccharides 2012 InTech Rijeka 617 634
117. A. Scherf, J.J. Lopez-Rubio, and L. Riviere Antigenic variation in Plasmodium falciparum Annu. Rev. Microbiol. 62 2008 445 470
118. O. Schneewind, and D. Missiakas Structural vaccinology to thwart antigenic variation in microbial pathogens Proc. Natl. Acad. Sci. USA 108 2011 10029 10030
119. L. Schofield, M.C. Hewitt, K. Evans, M.A. Siomos, and P.H. Seeberger Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria Nature 418 2002 785 789
120. B. Schumann, C. Anish, C.L. Pereira, and P.H. Seeberger Chapter 3 carbohydrate vaccines L.H. Jones, A.J. McKnight, Biotherapeutics: Recent Developments using Chemical and Molecular Biology 2013 The Royal Society of Chemistry London 68 104
121. P.H. Seeberger, and D.B. Werz Automated synthesis of oligosaccharides as a basis for drug discovery Nat. Rev. Drug Discov. 4 2005 751 763 (Pubitemid 43090496)
122. P.H. Seeberger, and D.B. Werz Synthesis and medical applications of oligosaccharides Nature 446 2007 1046 1051 (Pubitemid 46676067)
123. G. Sen, A.Q. Khan, Q. Chen, and C.M. Snapper In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands J. Immunol. 175 2005 3084 3091 (Pubitemid 41170528)
124. D.F. Smith, X.Z. Song, and R.D. Cummings Use of glycan microarrays to explore specificity of glycan-binding proteins Methods Enzymol. 480 2010 417 444
125. K.E. Stein Thymus-independent and thymus-dependent responses to polysaccharide antigens J. Infect. Dis. 165 Suppl 1 1992 S49 S52
126. C. Stockdale, M.R. Swiderski, J.D. Barry, and R. McCulloch Antigenic variation in Trypanosoma brucei: joining the DOTs PLoS Biol. 6 2008 e185
127. A.W. Sturgess, K. Rush, R.J. Charbonneau, J.I. Lee, D.J. West, R.D. Sitrin, and J.P. Hennessy Jr. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide Vaccine 17 1999 1169 1178 (Pubitemid 29132951)
128. S.C. Szu, X.R. Li, A.L. Stone, and J.B. Robbins Relation between structure and immunologic properties of the Vi capsular polysaccharide Infect. Immun. 59 1991 4555 4561
129. P. Talaga, S. Vialle, and M. Moreau Development of a high-performance anion-exchange chromatography with pulsed-amperometric detection based quantification assay for pneumococcal polysaccharides and conjugates Vaccine 20 2002 2474 2484 (Pubitemid 34615585)
130. M. Tamborrini, X. Liu, J.P. Mugasa, Y.U. Kwon, F. Kamena, P.H. Seeberger, and G. Pluschke Synthetic glycosylphosphatidylinositol microarray reveals differential antibody levels and fine specificities in children with mild and severe malaria Bioorg. Med. Chem. 18 2010 3747 3752
131. P. Teodorović, R. Slättegård, and S. Oscarson Synthesis of stable C-phosphonate analogues of Neisseria meningitidis group A capsular polysaccharide structures using modified Mitsunobu reaction conditions Org. Biomol. Chem. 4 2006 4485 4490 (Pubitemid 44847976)
132. Y.H. Tsai, X. Liu, and P.H. Seeberger Chemical biology of glycosylphosphatidylinositol anchors Angew. Chem. Int. Ed. Engl. 51 2012 11438 11456
133. T.I. Tsai, H.Y. Lee, S.H. Chang, C.H. Wang, Y.C. Tu, Y.C. Lin, D.R. Hwang, C.Y. Wu, and C.H. Wong Effective sugar nucleotide regeneration for the large-scale enzymatic synthesis of Globo H and SSEA4 J. Am. Chem. Soc. 135 2013 14831 14839
134. U.S. Department of Health and Human Services Recommended Immunizations for Children 2012 U.S. Department of Health and Human Services Washington
135. V. Verez-Bencomo, V. Fernández-Santana, E. Hardy, M.E. Toledo, M.C. Rodríguez, L. Heynngnezz, A. Rodriguez, A. Baly, L. Herrera, and M. Izquierdo et al. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b Science 305 2004 522 525 (Pubitemid 38971343)
136. S. Villeneuve, H. Souchon, M.-M. Riottot, J.-C. Mazié, P. Lei, C.P.J. Glaudemans, P. Kovác, J.-M. Fournier, and P.M. Alzari Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity Proc. Natl. Acad. Sci. USA 97 2000 8433 8438 (Pubitemid 30639690)
137. P. Vince, C. Bruce, P.J.G. Cornelis, S. Rachel, and B.R. John Towards an oligosaccharide-based glycoconjugate vaccine against shigella dysenteriae type 1 ChemInform 2003 10.1002/chin.200329260 Published online July 9, 2003
138. G.S. Visvesvara, and L.S. Garcia Culture of protozoan parasites Clin. Microbiol. Rev. 15 2002 327 328 (Pubitemid 34761342)
139. B. Vulliez-Le Normand, F.A. Saul, A. Phalipon, F. Bélot, C. Guerreiro, L.A. Mulard, and G.A. Bentley Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody Proc. Natl. Acad. Sci. USA 105 2008 9976 9981
140. L.X. Wang, J. Ni, S. Singh, and H. Li Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design Chem. Biol. 11 2004 127 134 (Pubitemid 38203997)
141. J. Wang, H. Li, G. Zou, and L.X. Wang Novel template-assembled oligosaccharide clusters as epitope mimics for HIV-neutralizing antibody 2G12. Design, synthesis, and antibody binding study Org. Biomol. Chem. 5 2007 1529 1540 (Pubitemid 46959421)
142. C.H. Wang, S.T. Li, T.L. Lin, Y.Y. Cheng, T.H. Sun, J.T. Wang, T.J.R. Cheng, K.K.T. Mong, C.H. Wong, and C.Y. Wu Synthesis of Neisseria meningitidis
143. Z. Wang, Z.S. Chinoy, S.G. Ambre, W. Peng, R. McBride, R.P. de Vries, J. Glushka, J.C. Paulson, and G.J. Boons A general strategy for the chemoenzymatic synthesis of asymmetrically branched N-glycans Science 341 2013 379 383
144. D.B. Werz, and P.H. Seeberger Total synthesis of antigen bacillus anthracis tetrasaccharide-creation of an anthrax vaccine candidate Angew. Chem. Int. Ed. 44 2005 6315 6318 (Pubitemid 41454652)
145. M.R. Wessels, L.C. Paoletti, H.K. Guttormsen, F. Michon, A.J. D'Ambra, and D.L. Kasper Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy Infect. Immun. 66 1998 2186 2192 (Pubitemid 28194119)
146. R. Woods, and A. Yongye Computational techniques applied to defining carbohydrate antigenicity P. Kosma, S. Müller-Loennies, Anticarbohydrate Antibodies 2012 Springer Vienna 361 383
147. World Health Organization Recommendations for the production and control of Haemophilus influenzae type b conjugate vaccines World Health Organ. Tech. Rep. Ser. 897 2000 27 60
148. World Health Organization Recommendations for the Production & Control of Pneumococcal Conjugate Vaccines 2003 World Health Organization Geneva
149. World Health Organization Recommendations for diphtheria, tetanus, pertussis and combined vaccines (Amendments 2003) World Health Organ. Tech. Rep. Ser. 927 2005 138 147
150. World Health Organization Recommendations to Assure the Quality, Safety and Efficacy of Group A Meningococcal Conjugate Vaccines 2006 World Health Organization Geneva
151. World Health Organization Recommendations to Assure the Quality, Safety and Efficacy of Pneumococcal Conjugate Vaccines 2009 World Health Organization Geneva
152. World Health Organization Chagas disease (American trypanosomiasis) - fact sheet (revised in August 2012) Wkly. Epidemiol. Rec. 87 2012 519 522
153. World Health Organization Recommendations to Assure the Quality, Safety and Efficacy of DT-based Combined Vaccines 2012 World Health Organization Geneva
154. C.Y. Wu, and C.H. Wong Programmable one-pot glycosylation Top. Curr. Chem. 301 2011 223 252
155. J. Zhu, J.D. Warren, and S.J. Danishefsky Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience Expert Rev. Vaccines 8 2009 1399 1413
156. W. Zou, R. Mackenzie, L. Thérien, T. Hirama, Q. Yang, M.A. Gidney, and H.J. Jennings Conformational epitope of the type III group B Streptococcus capsular polysaccharide J. Immunol. 163 1999 820 825 (Pubitemid 29328090)